AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

Fleisher served as chief medical officer and director of the Center for Clinical Standards and Quality at the CMS from 2020 to 2023. When I started leading the Center for Clinical Standards and ...

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the ...

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 ...

The MarketWatch News Department was not involved in the creation of this content. -- Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026 -- DENALI Part 2 trial topline ...